+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neutropenia Drug"

Neutropenia - Pipeline Insight, 2023 - Product Thumbnail Image

Neutropenia - Pipeline Insight, 2023

  • Clinical Trials
  • July 2023
  • 60 Pages
  • Global
From
From
From
From
Chemotherapy Induced Neutropenia - Pipeline Insight, 2022 - Product Thumbnail Image

Chemotherapy Induced Neutropenia - Pipeline Insight, 2022

  • Clinical Trials
  • July 2022
  • 60 Pages
  • Global
From
Febrile Neutropenia - Pipeline Insight, 2022 - Product Thumbnail Image

Febrile Neutropenia - Pipeline Insight, 2022

  • Clinical Trials
  • June 2022
  • 65 Pages
  • Global
From
From
From
Febrile Neutropenia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Febrile Neutropenia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2020 - Product Thumbnail Image

Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Neutropenia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Neutropenia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 323 Pages
  • Global
From
Febrile Neutropenia Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Febrile Neutropenia Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 140 Pages
  • Global
From
Loading Indicator

Neutropenia Drug is a type of drug used to treat immune disorders, specifically those that involve a decrease in the number of neutrophils, a type of white blood cell. Neutropenia can be caused by a variety of conditions, including chemotherapy, radiation therapy, and certain infections. Neutropenia drugs are designed to increase the number of neutrophils in the body, helping to reduce the risk of infection and other complications. These drugs are typically administered intravenously or orally, depending on the severity of the condition. The Neutropenia Drug market is highly competitive, with a number of companies offering products to treat this condition. Some of the major players in this market include Amgen, Novartis, Pfizer, Merck, and Roche. These companies offer a range of products, including monoclonal antibodies, cytokines, and other biologics. Additionally, there are a number of smaller companies that offer generic versions of these drugs. Show Less Read more